3.90
price down icon3.23%   -0.13
after-market 시간 외 거래: 3.94 0.04 +1.03%
loading

Phathom Pharmaceuticals Inc 주식(PHAT)의 최신 뉴스

pulisher
Apr 21, 2025

Alliancebernstein L.P. Has $370,000 Holdings in Phathom Pharmaceuticals, Inc. (NASDAQ:PHAT) - Defense World

Apr 21, 2025
pulisher
Apr 20, 2025

The Goldman Sachs Group Cuts Phathom Pharmaceuticals (NASDAQ:PHAT) Price Target to $10.00 - Defense World

Apr 20, 2025
pulisher
Apr 18, 2025

Why We're Not Concerned Yet About Phathom Pharmaceuticals, Inc.'s (NASDAQ:PHAT) 27% Share Price Plunge - simplywall.st

Apr 18, 2025
pulisher
Apr 17, 2025

Phathom Pharmaceuticals (NASDAQ:PHAT) shareholders have endured a 87% loss from investing in the stock five years ago - Yahoo Finance

Apr 17, 2025
pulisher
Apr 16, 2025

Phathom Pharmaceuticals appoints Ted Schroeder to board By Investing.com - Investing.com South Africa

Apr 16, 2025
pulisher
Apr 16, 2025

Phathom Pharmaceuticals appoints new board member By Investing.com - Investing.com South Africa

Apr 16, 2025
pulisher
Apr 16, 2025

Phathom Pharmaceuticals appoints new board member - Investing.com

Apr 16, 2025
pulisher
Apr 16, 2025

Phathom Pharmaceuticals Appoints Ted Schroeder to its Board of D - GuruFocus

Apr 16, 2025
pulisher
Apr 16, 2025

Phathom Pharmaceuticals Appoints Theodore Schroeder to Board - TipRanks

Apr 16, 2025
pulisher
Apr 16, 2025

Phathom Pharmaceuticals Appoints Ted Schroeder To Its Board Of Directors - marketscreener.com

Apr 16, 2025
pulisher
Apr 16, 2025

Phathom Pharmaceuticals appoints Ted Schroeder to board - Investing.com

Apr 16, 2025
pulisher
Apr 16, 2025

Phathom Pharmaceuticals Appoints Ted Schroeder to its Board of Directors - GlobeNewswire

Apr 16, 2025
pulisher
Apr 16, 2025

Strategic Win: Phathom Taps 30-Year Pharma Veteran to Drive VOQUEZNA Commercial Success - Stock Titan

Apr 16, 2025
pulisher
Apr 16, 2025

Vanguard Group Inc. Increases Stake in Phathom Pharmaceuticals, Inc. (NASDAQ:PHAT) - Defense World

Apr 16, 2025
pulisher
Apr 14, 2025

Wellington Management Group LLP Reduces Holdings in Phathom Pharmaceuticals, Inc. (NASDAQ:PHAT) - Defense World

Apr 14, 2025
pulisher
Apr 12, 2025

Phathom Pharmaceuticals’ (PHAT) “Buy” Rating Reiterated at Needham & Company LLC - Defense World

Apr 12, 2025
pulisher
Apr 12, 2025

9,100 Shares in Phathom Pharmaceuticals, Inc. (NASDAQ:PHAT) Acquired by KLP Kapitalforvaltning AS - Defense World

Apr 12, 2025
pulisher
Apr 09, 2025

Phathom Pharmaceuticals stock hits 52-week low at $4.07 By Investing.com - Investing.com Canada

Apr 09, 2025
pulisher
Apr 09, 2025

Phathom Pharmaceuticals stock hits 52-week low at $4.07 - Investing.com

Apr 09, 2025
pulisher
Apr 08, 2025

Phathom Pharmaceuticals CFO Molly Henderson sells $16,739 in stock By Investing.com - Investing.com Canada

Apr 08, 2025
pulisher
Apr 08, 2025

Phathom Pharmaceuticals CFO Molly Henderson sells $16,739 in stock - Investing.com

Apr 08, 2025
pulisher
Apr 08, 2025

Rhythm Pharmaceuticals (RYTM) Surges 17.1%: Is This an Indication of Further Gains? - Yahoo Finance

Apr 08, 2025
pulisher
Apr 07, 2025

Commonwealth Equity Services LLC Acquires 40,362 Shares of Phathom Pharmaceuticals, Inc. (NASDAQ:PHAT) - Defense World

Apr 07, 2025
pulisher
Apr 07, 2025

Selling Phathom Pharmaceuticals Shares at a Lower Price Than Current Market Value May Have Been a Costly Mistake for Insiders - simplywall.st

Apr 07, 2025
pulisher
Apr 07, 2025

Analysts Set Phathom Pharmaceuticals, Inc. (NASDAQ:PHAT) PT at $22.17 - Defense World

Apr 07, 2025
pulisher
Apr 04, 2025

Guggenheim Reiterates “Buy” Rating for Phathom Pharmaceuticals (NASDAQ:PHAT) - Defense World

Apr 04, 2025
pulisher
Apr 04, 2025

Needham & Company LLC Reaffirms Buy Rating for Phathom Pharmaceuticals (NASDAQ:PHAT) - Defense World

Apr 04, 2025
pulisher
Apr 03, 2025

Phathom Pharmaceuticals: The Clock Is Ticking On Voquezna (Downgrade) (PHAT) - Seeking Alpha

Apr 03, 2025
pulisher
Apr 03, 2025

Phathom Pharmaceuticals to Present at the 24th Annual Needham Virtual Healthcare Conference - GlobeNewswire

Apr 03, 2025
pulisher
Apr 03, 2025

GI Disease Leader Phathom Takes Center Stage at Major Healthcare Conference - Stock Titan

Apr 03, 2025
pulisher
Apr 02, 2025

Craig-Hallum Keeps Their Buy Rating on Phathom Pharmaceuticals (PHAT) - The Globe and Mail

Apr 02, 2025
pulisher
Apr 02, 2025

Needham Remains a Buy on Phathom Pharmaceuticals (PHAT) - The Globe and Mail

Apr 02, 2025
pulisher
Apr 02, 2025

Critical Analysis: Quoin Pharmaceuticals (NASDAQ:QNRX) & Phathom Pharmaceuticals (NASDAQ:PHAT) - Defense World

Apr 02, 2025
pulisher
Apr 02, 2025

When (PHAT) Moves Investors should Listen - news.stocktradersdaily.com

Apr 02, 2025
pulisher
Apr 01, 2025

Change at the top for Phathom as Basta replaces Curran - biocentury.com

Apr 01, 2025
pulisher
Apr 01, 2025

Phathom Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4) - MarketScreener

Apr 01, 2025
pulisher
Apr 01, 2025

Phathom Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire

Apr 01, 2025
pulisher
Apr 01, 2025

Phathom's New CEO Stakes Future on Stock Price and Revenue Goals - Stock Titan

Apr 01, 2025
pulisher
Apr 01, 2025

Phathom Pharmaceuticals Announces Leadership Transition in 2025 - TipRanks

Apr 01, 2025
pulisher
Apr 01, 2025

Phathom Pharmaceuticals Names Steven Basta CEO - MarketScreener

Apr 01, 2025
pulisher
Apr 01, 2025

Phathom Pharmaceuticals Announces Leadership Succession - MarketScreener

Apr 01, 2025
pulisher
Apr 01, 2025

Phathom Pharmaceuticals appoints new CEO - Investing.com

Apr 01, 2025
pulisher
Mar 31, 2025

Kenan Thompson partners with Phathom for GERD treatment By Investing.com - Investing.com Philippines

Mar 31, 2025
pulisher
Mar 31, 2025

Kenan Thompson partners with Phathom for GERD treatment - Investing.com India

Mar 31, 2025
pulisher
Mar 31, 2025

Actor and Comedian Kenan Thompson Teams Up with Phathom Pharmaceuticals to Raise Awareness About GERD and VOQUEZNA® (vonoprazan) - The Manila Times

Mar 31, 2025
pulisher
Mar 31, 2025

Actor and Comedian Kenan Thompson Teams Up with Phathom - GlobeNewswire

Mar 31, 2025
pulisher
Mar 31, 2025

SNL Legend Kenan Thompson Reveals Personal GERD Battle, Champions New Breakthrough Treatment - Stock Titan

Mar 31, 2025
pulisher
Mar 31, 2025

Virtu Financial LLC Acquires New Stake in Phathom Pharmaceuticals, Inc. (NASDAQ:PHAT) - Defense World

Mar 31, 2025
pulisher
Mar 28, 2025

Raymond James Financial Inc. Takes Position in Phathom Pharmaceuticals, Inc. (NASDAQ:PHAT) - Defense World

Mar 28, 2025
pulisher
Mar 28, 2025

Charles Schwab Investment Management Inc. Has $2.87 Million Holdings in Phathom Pharmaceuticals, Inc. (NASDAQ:PHAT) - Defense World

Mar 28, 2025
pulisher
Mar 26, 2025

Bank of New York Mellon Corp Purchases 4,557 Shares of Phathom Pharmaceuticals, Inc. (NASDAQ:PHAT) - Defense World

Mar 26, 2025
pulisher
Mar 19, 2025

Jefferies cuts Phathom Pharmaceuticals target to $13 By Investing.com - Investing.com UK

Mar 19, 2025
pulisher
Mar 19, 2025

Jefferies Cuts Price Target on Phathom Pharmaceuticals to $13 From $17, Maintains Buy Rating - MarketScreener

Mar 19, 2025
$20.07
price up icon 0.15%
$69.51
price down icon 4.32%
$32.19
price down icon 1.26%
$25.22
price up icon 2.48%
$101.81
price up icon 3.09%
biotechnology ONC
$229.22
price down icon 0.76%
자본화:     |  볼륨(24시간):